Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype

Wolfram syndrome (WS), also known as a DIDMOAD (diabetes insipidus, early-onset diabetes mellitus, optic nerve atrophy and deafness) is a rare autosomal disorder caused by mutations in the Wolframin1 (<i>WFS1</i>) gene. Previous studies have revealed that glucagon-like peptide-1 receptor...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Toomas Jagomäe, Kadri Seppa, Riin Reimets, Marko Pastak, Mihkel Plaas, Miriam A. Hickey, Kaia Grete Kukker, Lieve Moons, Lies De Groef, Eero Vasar, Allen Kaasik, Anton Terasmaa, Mario Plaas
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	wolfram syndrome Wfs1 GLP1 receptor agonist liraglutide rat model neurodegeneration Biology (General) QH301-705.5
Acceso en línea:	https://doaj.org/article/baf6b0dceefa49f8af4e77d5cbd8b3b4
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Early Intervention and Lifelong Treatment with GLP1 Receptor Agonist Liraglutide in a Wolfram Syndrome Rat Model with an Emphasis on Visual Neurodegeneration, Sensorineural Hearing Loss and Diabetic Phenotype

Ejemplares similares